https://ipharmag.com/adcs-continue-to-make-first-line-inroads-in-triple-negative-breast-cancer/ 2026-07-11T06:06:24+00:00 https://ipharmag.com/600-dead-in-outbreak-obamacare-now-trumpcare-rare-cancer-cluster-in-kids/ 2026-07-11T06:06:24+00:00 https://ipharmag.com/alzheimers-research-preparing-for-precision-medicine/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/fda-approves-pembrolizumab-combo-for-bladder-cancer/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/specialist-explores-neuroadaptation-to-presbyopia-correcting-iols/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/phase-3-trial-to-study-urcosimod-in-neuropathic-corneal-pain/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/converting-to-copper-surfaces-may-reduce-hospital-infection-rates/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/nicotine-pouches-linked-with-complications-after-achilles-surgery/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/one-third-of-dermatologists-in-academia-leave-within-7-years/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/study-bacterial-meningitis-rare-in-well-appearing-infants-with-fever/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/older-man-presents-with-new-onset-binocular-vertical-diplopia/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/study-same-day-coadministration-of-covid-19-and-flu-shots-safe/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/finerenone-may-show-blood-pressure-benefits-in-heart-failure/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/asedebart-may-lower-urinary-free-cortisol-in-cushings-disease/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/gluteal-tendon-tears-treated-open-vs-endoscopically/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/remote-rehab-fails-to-improve-quality-of-life-in-icu-survivors/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/cat-ownership-not-linked-to-asthma-exacerbations-in-kids/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/extreme-heat-patterns-may-affect-cancer-care/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/regulate-or-ban-experts-debate-future-of-direct-to-consumer-drug-advertising/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/fda-clears-ai-powered-screening-software-for-diabetic-retinopathy-2/ 2026-07-11T06:06:38+00:00 https://ipharmag.com/they-harvest-the-nations-food-but-a-new-rule-may-strip-them-of-health-insurance/ 2026-07-11T06:06:53+00:00 https://ipharmag.com/wp-content/uploads/2026/07/Farmworker-scaled.jpg https://ipharmag.com/a-new-option-for-long-term-care-costs/ 2026-07-11T06:06:56+00:00 https://ipharmag.com/wp-content/uploads/2026/07/GettyImages-1343268062-scaled.jpg https://ipharmag.com/meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-6-9-july-2026/ 2026-07-11T06:07:42+00:00 https://ipharmag.com/14-advancing-breast-cancer-diagnosis-in-rural-kenya-bridging-histopathological-gaps-toward-global-breast-cancer-initiative-gbci-goals/ 2026-07-11T06:09:28+00:00 https://ipharmag.com/15-technique-of-surgeon-performed-intraoperative-regional-pectoral-nerve-block-for-patients-undergoing-mastectomy/ 2026-07-11T06:09:28+00:00 https://ipharmag.com/how-does-orca-t-compare-with-post-transplant-cyclophosphamide-for-gvhd/ 2026-07-11T06:09:28+00:00 https://ipharmag.com/fda-rejects-rivoceranib-camrelizumab-in-first-line-unresectable-hcc/ 2026-07-11T06:09:28+00:00 https://ipharmag.com/do-venetoclax-dose-modifications-compromise-aml-outcomes/ 2026-07-11T06:09:28+00:00 https://ipharmag.com/fda-oks-pembrolizumab-ev-combo-in-muscle-invasive-bladder-cancer/ 2026-07-11T06:09:28+00:00 https://ipharmag.com/advancing-ocular-oncology-liquid-biopsies-and-vision-preserving-innovations/ 2026-07-11T06:09:28+00:00 https://ipharmag.com/fda-approves-subcutaneous-isatuximab-in-multiple-myeloma/ 2026-07-11T06:09:28+00:00 https://ipharmag.com/relapsed-refractory-multiple-myeloma-interpreting-monumental-3-efficacy-and-safety-findings/ 2026-07-11T06:09:29+00:00 https://ipharmag.com/assessing-bleeding-and-variceal-risk-before-anti-vegf-therapy-in-hcc/ 2026-07-11T06:09:29+00:00 https://ipharmag.com/relapsed-refractory-multiple-myeloma-rationale-and-design-of-the-monumental-3-study/ 2026-07-11T06:09:29+00:00 https://ipharmag.com/weighing-long-term-survival-and-quality-of-life-with-atezolizumab-plus-bevacizumab/ 2026-07-11T06:09:29+00:00